Standard Total Current Liabilities from 2010 to 2026

LAB Stock  USD 0.96  0.03  3.23%   
This page tracks Standard Biotools's Total Current Liabilities across reporting periods, highlighting trend direction and inflection points. Mean-reversion tendencies in this metric may inform forward estimates. Standard Biotools' Total Current Liabilities is decreasing over recent years with slightly volatile volatility. It is projected to reach approximately 113.7 M this year. Total Current Liabilities is the total amount of liabilities that Standard Biotools is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
 First Reported
2007-12-31
 Previous Quarter
108 M
 Current Value
108.3 M
 Quarterly Volatility
28.7 M
Macro event markers
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Analyzing Standard Biotools's Total Current Liabilities over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Total Current Liabilities has evolved provides context for assessing Standard Biotools's current valuation and future prospects.

Latest Standard Biotools' Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of Standard Biotools over the last few years. Total Current Liabilities is an item on Standard Biotools balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Standard Biotools are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Standard Biotools' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Standard Biotools' overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Slightly volatile
   Total Current Liabilities   
       Timeline  

Standard Total Current Liabilities Regression Statistics

Arithmetic Mean 46,677,729
Geometric Mean 36,247,828
Coefficient Of Variation 72.54
Mean Deviation 26,000,356
Median 33,474,000
Standard Deviation 33,860,198
Sample Variance1146.5T
Range106.6M
R-Value 0.88
Mean Square Error266.6T
R-Squared 0.78
Slope 5,929,562
Total Sum of Squares18344.2T

Standard Total Current Liabilities History

2026113.7 M
2025108.3 M
202465.9 M
2023109.3 M
202243.4 M
202149.6 M
202054.2 M

Methodology, Assumptions & Data Sources

This page provides reference data for Standard Biotools's Total Current Liabilities, tracking historical values and trends over time. Historical range context helps calibrate expectations for future readings.

Unless otherwise specified, data for Standard Biotools is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board
Last reviewed on March 16th, 2026